Salus University and Eyesafe Sign Research Agreement to Study Blue Light and Screen Time

By Staff
Tuesday, October 15, 2019 12:21 AM ELKINS PARK, Pa.—Salus University and Eyesafe have signed a Memorandum of Understanding to partner in a research project about the potential health hazards and protective solutions related to blue light. The first edition of this handbook, titled How to Save Your Eyes in the Digital Age, features optometrists, ophthalmologists, and scientists researching a variety of topics related to blue light and some of the proactive steps the electronics industry could take to tackle this emerging issue.

Lighthouse Guild Honors Two Vision Researchers

By Staff
Tuesday, October 15, 2019 12:15 AM NEW YORK—Lighthouse Guild presented the Bressler Prize to Vladimir Kefalov, PhD, and the Pisart Award to Tiffany Schmidt, PhD, at the 2019 Alfred W. Bressler Vision Science Symposium and Pisart Seminar in New York on Saturday, Oct. 5. “These two outstanding researchers, chosen by an independent panel of judges who are leading physicians and scientists in the field of vision care and research, are being recognized for their significant contributions to vision science and research,” said Alan R. Morse, JD, PhD, president and CEO of Lighthouse Guild.

Vivior Clears Key Regulatory Hurdle in Advance of U.S. Launch

By Staff
Monday, October 14, 2019 12:24 AM ZURICH—The U.S. Food and Drug Administration’s (FDA) has approved the regulatory strategy for the Vivior Monitor, a device that collects patient data used in cataract and refractive surgery. The move helps pave the way for Vivior’s U.S. launch of the Monitor, a wearable device that tracks and records the patient's behavioral data prior to vision correction interventions. The system collects daily activity data from patients, processes the data in the cloud, and patient's lifestyle patterns using machine-learning algorithms. It provides the surgeon with a patient report so that the surgeon can educate the patient during the pre-op planning discussion.

World Health Organization Launches First World Report on Vision

By Staff
Thursday, October 10, 2019 12:27 AM GENEVA—More than 1 billion people worldwide are living with vision impairment because they do not get the care they need for conditions like short and far sightedness, glaucoma and cataract, according to the first World Report on Vision issued by the World Health Organization. The report, launched ahead of World Sight Day (Oct. 10), found that ageing populations, changing lifestyles and limited access to eyecare, particularly in low- and middle-income countries, are among the main drivers of the rising numbers of people living with vision impairment.

California State Senate Designates Oct. 10 as Blue Light Awareness Day

By Staff
Thursday, October 10, 2019 12:21 AM NEW YORK—There are an estimated five billion mobile devices in use globallywith the average person spending over nine hours a day bouncing between digital screens. Recent studies show growing concerns over health implications and visual discomfort associated with blue light overexposure, which impacts 73 percent of adults under 30 years old, and 65 percent of all Americans.  Recognizing this worldwide epidemic, the California State Senate has designated October 10 as Blue Light Awareness Day—appropriate given the estimated 80 million mobile devices in use statewide. 

Eye Health America Adds an MD and an OD to Board

By Staff
Wednesday, October 9, 2019 12:15 AM
ATLANTA—Eye Health America (EHA), an eyecare practice management company, has named two new board members: ophthalmologist Dr. Joseph Parisi and optometrist Dr. Scott Han. Both practicing physicians bring expertise in clinical care, patient experience and practice management to the board, as EHA continues to expand as one of the Southeast’s fastest growing, fully integrated eye health networks. Since its formation in March 2018, EHA has increased its network to include 47 providers spanning optical, medical and surgical.

Vision 2020 USA to Hold Briefing About World Sight Day in Wash. D.C.

By Staff
Tuesday, October 8, 2019 12:27 AM CHICAGO—As part of World Sight Day events, Vision 2020 USA will be holding an educational luncheon briefing in Washington D.C. At this briefing Michael Chiang, MD, a leading national figure in artificial intelligence and big data analytics research, will discuss where the field is headed. Dr. Chiang, Professor of Ophthalmology & Medical Informatics and Clinical Epidemiology at the Oregon Health and Science University and technical adviser to the American Academy of Ophthalmology, will highlight the importance of federal leadership to ensure that the U.S. will realize full potential of these exciting new technologies. The briefing will be held Oct. 10 at the Rayburn House Office Building, Room 2075, from noon to 1 p.m. The session will be moderated by Dr. Mitchell Brinks, MD, MPH, Chair of Vision 2020/USA, who will lead off the event with an update on Vision 2020 USA activities.

CorneaGen Raises $37 Million to Advance Development of Cornea Cell Therapy

By Staff
Tuesday, October 8, 2019 12:21 AM
SEATTLE—CorneaGen, a Seattle-based company involved in cornea cell therapy research, has closed a $37 million Series B financing. The round was led by Flying L Partners in collaboration with Falcon Vision, a platform formed by KKR to advance innovation in ophthalmologyPetrichor Healthcare Capital Management also participated significantly in the equity round and provided a $25 million credit facility to provide additional growth capital to fund CorneaGen’s global expansion. “CorneaGen is dedicating significant resources to finding new ways to prevent and treat corneal blindness that can be scaled to reach people around the world,” said Bill Link, managing partner of Flying L Partners. “Advances and innovation in corneal treatments up until now have been limited due to the fragmentation of the global market. We see this important, underserved market as an opportunity for CorneaGen.”

GlobeChek Foundation Offers Free High-Tech Screening Eye Exams

By Staff
Thursday, October 3, 2019 12:21 AM VERO BEACH, Fla.—GlobeChek Foundation, a new philanthropy established by the founders of GlobeChek Enterprises, announced that it will provide free eyecare to those who lack access. The Vero Beach, Florida-based foundation was recently granted 501(c)(3) status. Having qualified as a nonprofit public charity, it can accept monetary donations from individuals and organizations, as well as in-kind donations of services from eyecare professionals. GlobeChek Enterprises, which has developed a mobile Eye Screening Globe (ESG) that enables thorough screening eye exams from remote locations, will donate a portion of its profits to the Foundation, according to William J. Mallon, MD and Adam Katz, MD, the ophthalmologists who founded both organizations. Those who make substantial tax-deductible contributions to the GlobeChek Foundation will be recognized with a plaque on a GlobeChek ESG unit or trailer, they said.

Many Employees Misunderstand Online Vision Screenings, New Survey Shows

By Staff
Friday, September 20, 2019 12:30 AM PINELLAS PARK, Fla.—Many people have misunderstandings about online vision screenings, according to newly released research from Transitions Optical and the American Optometric Association (AOA). Half of respondents polled in the Transitions Employee Perceptions of Vision Benefits survey think that online vision screenings that provide a prescription are a suitable replacement for in-office eye exams. Millennials were the most likely to agree (57 percent)—compared to half of Gen Z, Gen X and 36 percent of Boomers. The AOA points out that online vision screenings are “no substitute for an in-person, comprehensive eye exam by an optometrist.” Aside from correcting vision, comprehensive eye exams can detect a number of vision problems, eye diseases and overall health issues that online eye exams cannot—including glaucoma, high blood pressure and diabetes.

Wize Pharma Licenses Ophthalmic Non-viral Gene Therapy Technology

By Staff
Friday, September 13, 2019 12:15 AM
HOD HASHARON, Israel—Wize Pharma a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, has entered into an exclusive license agreement with U.S.-based Copernicus Therapeutics. The agreement grants Wize exclusive rights to license, develop and commercialize products based on a non-viral gene therapy technology developed by Copernicus for the treatment of choroideremia (CHM). "We are very pleased and excited to enter into this agreement with Copernicus. Their proprietary and innovative technology addresses what we believe to be the greatest challenges in gene therapy, including overcoming the potential immune system response to treatment, thereby allowing repeated treatments if necessary. As an ophthalmology focused company, Wize is eager to develop and commercialize this cutting-edge gene therapy to transform the treatment of eye related diseases," said Mark Sieczkarek, chairman of the board of directors of Wize.

Allyala Nandakumar and Serge Resnikoff Join Vision Impact’s Institute’s Advisory Board

By Staff
Thursday, September 12, 2019 12:18 AM The Vision Impact Institute (VII) announced two new additions to its global advisory board. Allyala Nandakumar, PhD, and Serge Resnikoff, MD, PhD, were approved as board members at the organization's meeting in July. Dr. Nandakumar brings his expertise as an internationally recognized health-financing expert to the board. Currently, he is Professor of the Practice at Brandeis University where he is the director of the master of science program in global health and development. In January 2018, Nandakumar was appointed the first chief economist at the office of the global AIDS coordinator at the U.S. Department of State. He served previously as the chief economist for the Global Health Bureau at USAID.

New Career Zone to Offer Full Day of Networking Events at Expo West

By Staff
Thursday, September 12, 2019 12:15 AM ALEXANDRIA, Va.—Available at Vision Expo West on Saturday, Sept. 21, only, the new Career Zone will offer an environment designed to connect corporate optical companies and associations with potential hires. “Following its success at Vision Expo East, the Career Zone will provide attendees a comfortable location to explore career and leadership opportunities from a variety of well-respected businesses,” said Joanne Mohr, Vision Expo event director of Reed Exhibitions. “Attendees can take advantage of unique access to discussions focused on career resources and hiring advice that could transform their professional endeavors.”

Review of Myopia Management Launches Updated Website Design

By Staff
Wednesday, September 11, 2019 12:15 AM NEW YORK—The September edition of Review of Myopia Management features the launch of an upgraded website design that provides easier access to its multichannel content. “Review of Myopia Management, the first and only publication dedicated to myopia, has received amazing feedback since its inception in March 2019. However, we’ve heard that sometimes the website was difficult to navigate. With the launch of our redesigned website, we’ve now made it intuitive for eyecare professionals to find the exact content they are looking for,” said Dwight Akerman OD, MBA, FAAO, chief medical editor of Review of Myopia Management.

BHVI Embarks on a New Program for Growth

By Staff
Tuesday, September 10, 2019 12:18 AM SYDNEY, Australia — Brien Holden Vision Institute (BHVI) announced that it is embarking on a new strategic roadmap, a process that included realigning its organizational structure. As part of the realignment, Dr. Arthur Back has been appointed managing director of VisionCRC, BHVI’s science arm which translates the organization’s research into commercial products. "We are excited to have Dr. Arthur Back join us. Dr Back invented more than 60 patents and commercialized 18 products while he was chief technology officer at CooperVision. Combined with the expertise of Professor Sankaridurg, a pioneer in the field of Myopia research, we are at the forefront of our industry,” said Yvette Waddell, CEO of BHVI.